Lv42
558 积分 2025-11-27 加入
Comparison of the recovery and half‐life of a high‐purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study Group
23小时前
已完结
Pharmacokinetics of recombinant and plasma-derived factor IX products in pediatric patients with severe hemophilia B
23小时前
已完结
Systematic review of clinical trials on antithrombotic therapy with factor XI inhibitors
2个月前
已完结
Perioperative Management of Patients Receiving Factor XI Inhibitors
2个月前
已完结
Systematic review of clinical trials on antithrombotic therapy with factor XI inhibitors
2个月前
已关闭
Development of new anticoagulants targeting coagulation factor XI and prospects for clinical use
2个月前
已完结
KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension – Evidence from preclinical models
2个月前
已完结
The Discovery of a Novel Anticoagulant Mechanism: Factor XI Activation Inhibitors
2个月前
已完结
Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors
2个月前
已完结
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions
2个月前
已完结
皖公网安备34019202002308